Determinación de lipoproteína (a) por electroinmunodifusión

Acta Bioquimica Clinica Latinoamericana

Volumn 31, Issue 2, 1997, Pages 195-203

  Coniglio, Raúl Ignacio ^a,c   Selles, Juana ^b,d   Malaspina, María Marcela ^a,d   Alvarez, Cristina ^b,d  

^a Ctro de Invest Biomédicas

^b Universidad del Sur   (Argentina)

^c Bioquímica Clínica

^d Bioquímica ^*

Author keywords

Coronary heart disease; Cutoff values; Electroimmunodiffusion; Lipoprotein (a); Methodology; Risk factors

Indexed keywords

EID: 0031505471     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. BERG, K., "A new serum type system in man: The Lp system", Acta Pathol. Microbiol. Scand., 59, 369-382, 1963.
2. SCANU, A. M., "Lp(a) as a marker for coronary heart disease risk", Clin. Cardiol., 14, 35-39, 1991.
3. SCANU, A. M., "Structural and functional polymorphism of lipoprotein (a): Biological and clinical implications", Clin. Chem., 41, 170-172, 1995.
4. MARCOVINA, S. M.; ALBERS, J. J.; GABEL, B.; KOSCHINSKY, M. L. and GAUR, V. P., "Effect of the number of apolipoprotein (a) kringle 4 on immunochemical measurements of lipoprotein (a)", Clin. Chem., 41, 246-255, 1995.
5. UTERMANN, G., "The mysteries of lipoprotein (a)", Science, 246, 904-910, 1989.
6. LACKNER, C.; COHEN, J. C. and HOBBS, H. H., "Molecular definition of the extreme size polymorphism in apolipoprotein (a)", Human Mol. Genet., 2, 933-940, 1993.
7. SANDHOLZER, C.; HALLMAN, D. M. and SAHA, N., "Effects of the apolipoprotein (a) size polymorphism on the lipoprotein (a) concentration in 7 ethnic groups", Hum. Genet., 86, 607-614, 1991.
8. MCLEAN, J. W.; TOMLINSON, J. E.; KUANG, W.J.; EATON, D. L.; CHEN, E. Y. and FLESS, G. M., "cDNA sequence of human lipoprotein (a) is homologous to plasminogen", Nature, 330, 132-137, 1987.
9. MARCOVINA, S. M. and MORRISETT, J. D., "Structure and metabolism of lipoprotein (a)", Current Opinion in Lipidology, 6, 136-145, 1995.
10. DAHLEN, G.; ERICSON, C.; FURBERG, C.; LUNDQUIST, K. and SVARDSUD, K., "Studies on an extra pre-beta lipoprotein fraction", Acta Med. Scand., 531, 1-28, 1972.
11. DAHLEN, G.; BERG, K.; GILLNAS, T. and ERICSON, C., "Lp(a) lipoprotein/prebetal-lipoprotein in Swedish middle-aged male and in patients with coronary heart disease", Clin. Genet., 7, 334-341, 1975.
12. KOSTNER, G. M.; AVOGARO, P.; CAZZOLATO, G.; MARTH, E.; BITTOLBON, G. and QUINCI, G. B., "Lipoprotein (a) and the risk for myocardial infarction", Atherosclerosis, 38, 50-61, 1981.
13. RHOADS, G. G.; DAHLEN, G.; BERG, K.; MORTON, N. E. and DANNENBERG, A. L., "Lp(a) lipoprotein as a risk factor for myocardial infarction", JAMA, 256, 2.540-2.544, 1986.
14. GENEST, J. J.; JENNER, H. and MCNAMARA, J. R., "Prevalence of lipoprotein (a) excess in coronary artery disease", Am. J. Cardiol., 67, 1.039-1.045, 1991.
15. ROSEGREN, A.; WILHELMSEM, L. and ERIKSSON, E., "Lipoprotein (a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men", British Med. J., 301, 1.248-1.251, 1990.
16. DURRINGTON, P. N.; ISHOLA, M. and HUNT, L., "Apolipoprotein (a), A-I, and B and parental history in men with early onset ischaemic heart disease", Lancet, 1, 1.070-1.073, 1988.
17. DESMARAIS, R. L.; SAREMBOCK, I. J.; AYERS, C. R.; VERNON, S. M.; POWERS, E. R. and GIMPLE, L. W., "Elevated serum lipoprotein (a) is a risk factor for clinical recurrence after Coronary Balloon Angioplasty", Circulation, 91, 1.403-1.409, 1995.
18. SHINTANI, S.; KIKUCHI, S.; HAMAGUCHI, H. and SHIIGAI, T., "High serum lipoprotein (a) are an independent risk factor for cerebral infarction", Stroke, 24, 965-969, 1993.
19. VALENTINE, R. L.; GRAYBURN, P. A.; VEGA, G. L. and GRUNDY, S. M., "Lp(a) is an independent discriminating risk factor for premature peripheral atherosclerosis among white men", Arch. Inter. Med., 154, 801-806, 1994.
20. BALOSSI, E. C. y HAUGER-KLEVENE, J. H., "Mortalidad por enfermedades cardiovasculares en la Repüblica Argentina", Rev. Arg. Cardiol., 53, 160-164, 1985.
21. CONIGLIO, R. I., "Determinación de apolipoproteína B por electroinmunodifusión en pacientes normo e hipercolesterolémicos", Acta Bioquím. Clín. Latinoam., 17, 401-408, 1983.
22. ALBERS, J. J. and HAZZARD, W. R., "Immunochemical quantification of human plasma Lp(a) lipoprotein", Lipids, 9, 15-26, 1974.
23. STEINMETZ, J.; TARALLO, P.; FOURNIER, B.; JAID, M.; CACES, E.; VOL, S.; TICHET, J.; SiEST, G., "Valeurs de référence de la lipoprotéine (a) dans une population française", Press Med., 23, 1.695-1.698, 1994.
24. SCANU, A. M. and FLESS, G. M., "Lipoprotein (a): heterogeneity and biological relevance", J. Clin. Invest., 85, 1.709-1.715, 1990.
25. ALBERS, J. J.; MARCOVINA, S. M. and LODGE, M. S., "The unique lipoprotein(a): Properties and immunochemical measurement", Clin. Chem., 36, 2.019-2.026, 1990.
26. ALBERS, J. J. and MARCOVINA, S. M., "Standarization of Lp(a) measurements", Chem. Phys. Lipids, 67/68, 257-263, 1994.
27. KOSTNER, G. M.; AVOGARO, P.; CAZZOLATO, G.; MARTH, E.; BITTOLBON, G. and QUINICI, G. B., "Lipoprotein Lp(a) and the risk for myocardial infarction", Atherosclerosis, 38, 51-61, 1981.
28. ARMSTRONG, V. W.; CREMER, P.; ERBELE, E.; MANKE, F.; SCHULZE, F.; WIELAND, H.; KREUZER, H. and SEIDEL, D., "The association between Lp(a) concentrations and angiographycally assessed coronary atherosclerosis: Dependence on serum LDL levels", Atherosclerosis, 62, 249-257, 1986.
29. SCHAEFER, E. J.; LAMON-FAVA, S.; JENNER, J.; MCNAMARA, J. R.; ORDOVAS, J. M.; DAVIS, E.; ABOLAFIA, J. M.; LIPPEL, K. and LEVY, R. I., "Lipoprotein (a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial", JAMA, 271, 999-1.003, 1994.
30. BOERWINKLE, E. and UTERMANN, G., "Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia", J. Engl. J. Med., 322, 1.494-1.499, 1990.
31. FONDA, M.; DA COL, P. G.; LA VERDE, B.; BATTELLO, C.; FISICARDO, M.; TONIZZO, M. and CATTIN, L., "Lipoprotein (a) serum concentration in familial combined hyperlipidemia", Clin. Chim. Acta, 223, 121-127, 1993.
32. RADER, R. J.; HOEG, J. M. and BREWEER, H. B., "Quantitation of plasma apolipoprotein in the primary and secondary prevention of coronary artery disease", Ann. Inter. Med., 120, 1.012-1.025, 1994.
33. MARCOVINA, S. M.; GAUR, V. P. and ALBERS, J. J., "Biological variability of cholesterol, triglyceride, low and high density lipoprotein cholesterol, lipoprotein (a) and apolipoproteins A-I and B", Clin. Chem., 40, 575-578, 1994.
34. AUSTIN, M. S. and HOKANSON, J. E., "Epidemiology of triglycerides, small dense low density lipoprotein, and lipoprotein (a) as risk factors for coronary heart disease", Med. Clin. N.A., 78, 99-115, 1994.
35. LOBO, R. A.; NOTELOVITZ, M.; BERNSTEIN, L.; KHAN, F. Y.; ROSS, R. K. and PAUL, W. L., "Lp(a) lipoprotein: Relationship to cardiovascular disease risk factors, exercise, and estrogen", Am. J. Ostet. Gynecol., 166, 1.182-1.190, 1992.
36. BERGLUND, L., "Diet and drug therapy for lipoprotein (a)", Current Opinion in Lipidology, 6, 48-56, 1995.